113 related articles for article (PubMed ID: 14668739)
21. Molecular genetic analysis of the von Hippel-Lindau and human peroxisome proliferator-activated receptor gamma tumor-suppressor genes in adenocarcinomas of the gastroesophageal junction.
Wijnhoven BP; Lindstedt EW; Abbou M; Ijzendoorn Y; de Krijger RR; Tilanus HW; Dinjens WN;
Int J Cancer; 2001 Dec; 94(6):891-5. PubMed ID: 11745495
[TBL] [Abstract][Full Text] [Related]
22. Somatic von Hippel-Lindau disease gene mutation in clear-cell renal carcinomas associated with end-stage renal disease/acquired cystic disease of the kidney.
Yoshida M; Yao M; Ishikawa I; Kishida T; Nagashima Y; Kondo K; Nakaigawa N; Hosaka M
Genes Chromosomes Cancer; 2002 Dec; 35(4):359-64. PubMed ID: 12378530
[TBL] [Abstract][Full Text] [Related]
23. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas.
Lee JY; Dong SM; Park WS; Yoo NJ; Kim CS; Jang JJ; Chi JG; Zbar B; Lubensky IA; Linehan WM; Vortmeyer AO; Zhuang Z
Cancer Res; 1998 Feb; 58(3):504-8. PubMed ID: 9458097
[TBL] [Abstract][Full Text] [Related]
24. Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions.
Trovato M; Ulivieri A; Dominici R; Ruggeri RM; Vitarelli E; Benvenga S; Barresi G; Trimarchi F; Brunetti E; Vecchione A; Andreoli M; Sciacchitano S
Endocr Relat Cancer; 2004 Jun; 11(2):365-76. PubMed ID: 15163311
[TBL] [Abstract][Full Text] [Related]
25. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients.
Lubensky IA; Gnarra JR; Bertheau P; Walther MM; Linehan WM; Zhuang Z
Am J Pathol; 1996 Dec; 149(6):2089-94. PubMed ID: 8952541
[TBL] [Abstract][Full Text] [Related]
26. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
[TBL] [Abstract][Full Text] [Related]
27. Molecular study of a new family with hereditary renal cell carcinoma and a translocation t(3;8)(p13;q24.1).
Meléndez B; Rodríguez-Perales S; Martínez-Delgado B; Otero I; Robledo M; Martínez-Ramírez A; Ruiz-Llorente S; Urioste M; Cigudosa JC; Benítez J
Hum Genet; 2003 Feb; 112(2):178-85. PubMed ID: 12522559
[TBL] [Abstract][Full Text] [Related]
28. A novel pancreatic endocrine tumor suppressor gene locus on chromosome 3p with clinical prognostic implications.
Chung DC; Smith AP; Louis DN; Graeme-Cook F; Warshaw AL; Arnold A
J Clin Invest; 1997 Jul; 100(2):404-10. PubMed ID: 9218518
[TBL] [Abstract][Full Text] [Related]
29. [Mutation of von Hippel-Lindau gene and expression of vascular endothelial growth factor in sporadic clear cell renal cell carcinoma and their relationships to angiogenesis].
Zhang N; Gong K; Guo HF; Na X; Wu G; Yang XY; Xin DQ; Na YQ
Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1620-4. PubMed ID: 15569457
[TBL] [Abstract][Full Text] [Related]
30. Somatic VHL gene deletion and point mutation in MEN 2A-associated pheochromocytoma.
Koch CA; Huang SC; Zhuang Z; Stolle C; Azumi N; Chrousos GP; Vortmeyer AO; Pacak K
Oncogene; 2002 Jan; 21(3):479-82. PubMed ID: 11821960
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
[TBL] [Abstract][Full Text] [Related]
32. Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status.
Ashida S; Furihata M; Tanimura M; Sugita O; Yamashita M; Miura T; Moriyama M; Shuin T
J Urol; 2003 Jun; 169(6):2089-93. PubMed ID: 12771725
[TBL] [Abstract][Full Text] [Related]
33. Fine analysis of the short arm of chromosome 1 in sporadic and familial pheochromocytoma.
Opocher G; Schiavi F; Vettori A; Pampinella F; Vitiello L; Calderan A; Vianello B; Murgia A; Martella M; Taccaliti A; Mantero F; Mostacciuolo ML
Clin Endocrinol (Oxf); 2003 Dec; 59(6):707-15. PubMed ID: 14974911
[TBL] [Abstract][Full Text] [Related]
34. [Abnormalities of tumor suppressor genes at chromosome 3p in lung cancer].
Li L; An Q; Feng X
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(7):399-401. PubMed ID: 11798905
[TBL] [Abstract][Full Text] [Related]
35. Comparison of epigenetic and genetic alterations in mucinous cystic neoplasm and serous microcystic adenoma of pancreas.
Kim SG; Wu TT; Lee JH; Yun YK; Issa JP; Hamilton SR; Rashid A
Mod Pathol; 2003 Nov; 16(11):1086-94. PubMed ID: 14614047
[TBL] [Abstract][Full Text] [Related]
36. Rare loss of heterozygosity of the MTS1 and MTS2 tumor suppressor genes in differentiated human thyroid cancer.
Schulte KM; Staudt S; Niederacher D; Finken-Eigen M; Köhrer K; Goretzki PE; Röher HD
Horm Metab Res; 1998 Sep; 30(9):549-54. PubMed ID: 9808321
[TBL] [Abstract][Full Text] [Related]
37. [Detailed mapping and clinical significance of loss of heterozygosity on 9p13-23 in laryngeal squamous cell carcinoma by microsatellite analysis].
Xu XF; Tang PZ; Cheng SJ
Ai Zheng; 2003 May; 22(5):452-7. PubMed ID: 12753701
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity in follicular and papillary thyroid carcinomas.
Rodrigues-Serpa A; Catarino A; Soares J
Cancer Genet Cytogenet; 2003 Feb; 141(1):26-31. PubMed ID: 12581895
[TBL] [Abstract][Full Text] [Related]
39. Clinical value of loss of heterozygosity in serum microsatellite DNA of patients with gastrointestinal stromal tumors.
Schurr PG; Oikonomou D; Kaifi JT; Merkert P; Wolter S; Kleinhans H; Reichelt U; Mann O; Gawad KA; Strate T; Yekebas EF; Izbicki JR
J Clin Gastroenterol; 2009 Jan; 43(1):27-35. PubMed ID: 18469721
[TBL] [Abstract][Full Text] [Related]
40. The genetic locus NRC-1 within chromosome 3p12 mediates tumor suppression in renal cell carcinoma independently of histological type, tumor microenvironment, and VHL mutation.
Lovell M; Lott ST; Wong P; El-Naggar A; Tucker S; Killary AM
Cancer Res; 1999 May; 59(9):2182-9. PubMed ID: 10232606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
